New Series on Personalized Medicine and the Brain (PMWC 2012)

On aver­age, the med­ica­tions pre­scribed for brain-relat­ed con­di­tions ben­e­fit approx­i­mate­ly 50% of patients.  But which 50%?.” “We need unam­bigu­ous bio­mark­ers that are clin­i­cal­ly rel­e­vant and scal­able at rea­son­able cost. They already exist in Can­cer.   But they do not yet exist in the Brain.” What may change that?

Read More

Improving Brain Health Outcomes with Tech, Incentives and Comparative Effectiveness Research

Mal­prac­tice Method­ol­o­gy (New York Times OpEd by Peter Orszag) Right now, health care is more evi­­dence-free than you might think. And even where evi­­dence-based clin­i­cal guide­lines exist, research sug­gests that doc­tors fol­low them only about half of the time. One esti­mate sug­gests that it takes 17 years on aver­age to incor­po­rate new research find­ings into…

Read More

Grand Rounds: 22 Health and Medicine Questions and Answers

Wel­come to Grand Rounds, the week­ly col­lec­tion of best health and med­ical blog posts. This week we invite you to enjoy a broad range of insights, tips, and first-hand sto­ries, pre­sent­ed as a Q&A con­ver­sa­tion with blog­gers will­ing to answer, below, a total of 22 good ques­tions. On Health and Med­i­cine What can one-word prescriptions…

Read More